Amy E. Schuh

Amy, a former senior vice president and chief ethics and compliance officer at a major information technology services company, enhanced its corporate ethics and compliance program, including by developing a robust global anti-corruption program. Amy worked closely with the US Department of Justice and US Securities and Exchange Commission (SEC) in connection with the company's ongoing reporting requirements in connection with its Foreign Corrupt Practices Act (FCPA) resolution. She also supported the company's active mergers and acquisitions (M&A) profile during due diligence and through integration.

Prior, Amy was the executive director of global investigations for a major international pharmaceutical company, where she managed a global team of lawyers responsible for conducting escalated internal investigations into alleged violations of the company’s code of conduct and for handling government investigations. She also enhanced the company’s compliance program, specifically as it related to its corporate policies and procedures and its global anti-corruption compliance program. Previously, in 2008, Amy was tapped to create a corporate compliance program for a Fortune 10 company.

Amy began her legal career as a litigation associate at Morgan Lewis and another global law firm. She is active in pro bono work, having co-founded and co-chaired a pro bono program that collaborated with the National Veterans Legal Services Program to help veterans access critical benefits. Amy has continued to serve on the board of directors since 2011 and is co-chair of the board. 

Representative Matters

• Provides ongoing counseling as issues arise to general counsel, chief compliance officers and other senior members of the compliance team across multiple industries, including life sciences, retail, defense, electric vehicle (EV), and technology
• Acted as global chief compliance officer for a privately held conglomerate with operations around the globe
• Counseled a global software company to enhance elements of its corporate ethics and compliance program, as well as its anticorruption compliance program, after its voluntary disclosure of potential bribery issues to the US Department of Justice (DOJ) in connection with the M&A Safe Harbor Policy
• Counseled a United Kingdom (UK)-headquartered company to enhance its anticorruption program after its voluntary disclosure of potential bribery issues to the DOJ, US Securities and Exchange Commission (SEC), and UK Serious Fraud Office (SFO) and presented on the effectiveness of their compliance program, which led to a declination by the DOJ
• Enhanced the ethics and compliance program of a conglomerate in anticipation of potential regulatory scrutiny
• Conducted maturity assessments of multiple  companies’ corporate and ethics programs vis-à-vis the DOJ’s Evaluation of Corporate Compliance Programs Guidelines and identified prioritized enhancements to those programs based on their level of maturity, industry, and size; clients included companies from various industries, including technology, healthcare, manufacturing, retail, energy, nonprofit, and technology
• Oversaw and directed a Fortune 10 company’s third-party anticorruption audits; provided recommendations for enhancements to its anticorruption program benchmarked against the company’s risk profile and regulator expectations
• Supported the development and implementation of ethics and compliance and anticorruption compliance program integration plans for multiple clients across industries, including manufacturing, energy, and investment firms
• Retained to review and/or create codes of conduct and other corporate policies and procedures across multiple industries
• Counsels companies around issues related to AI Governance

Risk Assessments

• Conducted a privileged and confidential risk assessment focused on 40 identified ethics and compliance risks, aligned with DOJ’s Evaluation of Corporate Compliance program on behalf of a US multinational semiconductor company
• Advises a global technology company on creating a unified corporate anticorruption compliance program; the team conducted risk assessments in multiple jurisdictions and is partnering with the client to develop a third-party due diligence program, revise anticorruption trainings, and rollout enterprise-wide compliance policies and procedures
• Advises a Northern European energy company on antibribery procedures and policies within the organization in relation to FCPA rules and the UK Bribery Act
• Oversees and directs a privileged and confidential risk assessment focused on a myriad of legal, regulatory and compliance risks for a global technology company
• Provides ongoing counseling to anticorruption compliance teams as issues arise across industries, including EV, telecom, and manufacturing

Investigation Program Evaluation, Enhancements and/or Build

• Assisted a large life sciences company with a review of investigations resources throughout the company (legal, ethics and compliance, security, and human resources) to ensure optimal structures and consistency of internal investigations processes
• Revised the Investigations Handbook, related templates, and training for two recently spun-out companies in the energy and pharmaceutical industries, streamlining and optimizing their investigation resources and processes to simplify and right-size their investigations resources and processes
• Revamped Internal Investigations Committee Charters, escalation processes, assignment matrices, disciplinary matrices, and Investigations Handbooks for a manufacturing company.
• Provided counseling to a large consulting firm and bank related to benchmarks for investigations programs, processes, and resources